UK-based pharma giant GlaxoSmithKline (GSK) is in talks to pick up a 5% stake in Hyderabad-based Dr Reddy’s Laboratories (DRL) in order to strengthen its association with the Indian firm with whom it had signed a marketing alliance four months ago.
The details can be read here.
No comments:
Post a Comment